Kyphoplasty and Percutaneous Discectomy Procedure Market Size to Exceed USD 3,619.2 Mn by 2032

The Kyphoplasty and Percutaneous Discectomy Procedure Market, estimated at USD 2,455.2 Mn in 2025, is expected to exhibit a CAGR of 5.7% and reach USD 3,619.2 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Increasing product launch by the key players in the market is expected to drive the market growth over the forecast period. For instance, in May 2025, the company launched Kyphon Assist Directional Cannula for use with its balloon kyphoplasty products to treat vertebral compression fractures due to osteoporosis, cancer or benign lesions. The Kyphon Assist Directional Cannula allows directional control of inflatable bone tamps during a balloon kyphoplasty procedure.

Global Kyphoplasty and Percutaneous Discectomy Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

The COVID-19 outbreak is anticipated to have a negative impact on the global kyphoplasty and percutaneous discectomy procedure market. Supply chain and manufacturing activities have been disrupted globally, due to lockdowns implemented by governments, restricted movement, and other COVID-19 safety precautions. The supply of raw materials and drugs required for kyphoplasty and percutaneous discectomy procedure has been severely disrupted due to the forced quarantine and lack of labor during the COVID-19 pandemic. As the link between regional warehouses is not smooth, the transportation of raw materials and drugs between regions cannot be carried out successfully. This shortage of raw materials and components has negatively affected the supply chain of the global kyphoplasty and percutaneous discectomy procedure market. Supply chains consist of producers of raw materials, manufacturing factories, transportation systems, and distribution networks. Critical medical supply manufacturing and distribution were hampered by the lockdown.

Global Kyphoplasty and Percutaneous Discectomy Market: Key Developments

In August 2025, IZI Medical Products, LLC, a manufacturer of interventional radiology devices, announced the official launch of its Osteo-Site Vertebral Balloon for vertebral augmentation. The Osteo-Site Balloon completes IZI's offering of Vertebral Compression Fracture ("VCF") treatment options, which include Osteo-Site Balloon Kyphoplasty, Blazer Curved Needle Augmentation, Osteo-Site Vertebroplasty, and Kiva PEEK Implant-based augmentation.

In October 2025, Johnson & Johnson announced that it had entered a co-marketing and distribution agreement, as well as an R&D agreement, with TINAVI, a market company of orthopedic robotics in China. This strategic collaboration will allow DePuy Synthes, the orthopaedics business of Johnson & Johnson Medical Devices Companiesto bring TINAVI’s robotic solutions for spine and trauma surgery to the highly competitive China orthopedics implant market.latable bone tamps during a balloon kyphoplasty procedure

Browse 61 Market Data Tables and 43 Figures spread through 217 Pages and in-depth TOC on “Global Kyphoplasty And Percutaneous Discectomy Market”-  Forecast to 2032, Global Kyphoplasty And Percutaneous Discectomy Market, by Procedure (Kyphoplasty and Percutaneous Discectomy), by Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis, and Others), by End User (Hospitals, Clinics, Ambulatory surgical centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/kyphoplasty-and-percutaneous-discsectomy-procedure-market-5456

Moreover, increasing inorganic strategies such as acquisitions by the key players is expected to drive the market growth over the forecast period. In December 2025, Spinal Elements, a spine technology company, announced the acquisition of the assets of Benvenue Medical, Inc., a developer of minimally invasive surgical (MIS) lumbar fusion systems. Among the assets were the Luna XD multi-expandable lumbar fusion device and the Orbit Articulating Discectomy System.

Key Takeaways of the Global Kyphoplasty and Percutaneous Discectomy Market:

• The global kyphoplasty and percutaneous discectomy market is expected to exhibit a CAGR of 5.7% during the forecast period due to the increasing product approval. For instance, in September 2025, eCential Robotics, a France-based MedTech company that designs and manufactures a system unifying 2D/3D imaging, surgical navigation, and robotics, announced the U.S. Food and Drug Administration (FDA) clearance of its 3D imaging, navigation, and robotics guidance system. The system consists of three mobile interconnected units: a mobile C-arm, a mobile viewing workstation, and a mobile collaborative robot. This system helps the surgeon to perform surgery such as minimally invasive surgery.
• Among end user, the hospital segment is estimated to hold a dominant position in the global kyphoplasty and percutaneous discectomy market over the forecast period, owing to the increasing prevalence of vertebral compression fractures. For instance, according to the data published by the American Journal of Medicine, in March 2025, vertebral compression fractures are the most common complication of osteoporosis, with 700,000 cases reported every year in the U.S.
• On the basis of regions, North America is estimated to account for the largest market share in the global kyphoplasty and percutaneous discectomy market over the forecast period, owing to increasing product launches by key players in the market. For instance, in October 2025, SeaSpine Holdings Corporation, a medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the full commercial launch of the 7D FLASH Navigation System Percutaneous Spine Module. The release of the Percutaneous Module represents a new solution for minimally invasive surgery.
• Major players operating in the global kyphoplasty and percutaneous discectomy market include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech